+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Scleroderma - Pipeline Insight, 2025 - Product Thumbnail Image

Scleroderma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Immune Thrombocytopenic Purpura - Pipeline Insight, 2025 - Product Thumbnail Image

Immune Thrombocytopenic Purpura - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Cerebral Infarction - Pipeline Insight, 2025 - Product Thumbnail Image

Cerebral Infarction - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mydriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Mydriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Osteonecrosis - Pipeline Insight, 2025 - Product Thumbnail Image

Osteonecrosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Hemochromatosis- Pipeline Insight, 2025 - Product Thumbnail Image

Hemochromatosis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
SMO Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

SMO Protein Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Acute Optic Neuritis - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Optic Neuritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Exportin-1 Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Exportin-1 Protein Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hepatitis C Virus Infection- Pipeline Insight, 2025 - Product Thumbnail Image

Hepatitis C Virus Infection- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
P Selectin Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

P Selectin Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Enhancer Of Zeste Homolog 2 Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Enhancer Of Zeste Homolog 2 Protein Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Zika Virus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Zika Virus Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Lipodystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Lipodystrophy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Opioid Kappa Receptor Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Opioid Kappa Receptor Agonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Amyloid Beta-protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Amyloid Beta-protein Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gilles De La Tourette's Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Gilles De La Tourette's Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Chronic Hand Eczema - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Hand Eczema - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hemophilia A -Pipeline Insight, 2025 - Product Thumbnail Image

Hemophilia A -Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more